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New antiparasitic substancesa b s t r a c t
Antimicrobial peptides (AMPs), which are differentiated from other antibiotic peptides, such as gramici-
dins and polymyxins, because they are synthesized by large enzymatic complex and bear modiﬁed amino
acids including D-amino acids, are short polymers of L-amino acids synthesized by ribosomes upon which
all living organisms rely to defend themselves from invaders or competitor microorganisms. AMPs have
received a great deal of attention from the scientiﬁc community as potential new drugs for neglected dis-
eases such as Leishmaniasis. In plants, they include several families of compounds, including the plant
defensins. The aim of the present study was to improve the expression of recombinant defensin from Vig-
na unguiculata seeds (Vu-Defr) and to test its activity against Leishmania amazonensis promatigotes.
Recombinant expression was performed in LB and TB media and under different conditions. The puriﬁ-
cation of Vu-Defr was achieved by immobilized metal ion afﬁnity and reversed-phase chromatography.
The puriﬁed Vu-Defr was analyzed by circular dichroism (CD), and its biological activity was tested
against L. amazonenis promastigotes. To demonstrate that the recombinant production of Vu-Defr did
not interfere with its fold and biological activity, the results of all experiments were compared with
the results from the natural defensin (Vu-Def). The CD spectra of both peptides presented good superim-
position indicating that both peptides present very similar secondary structure and that the Vu-Defr was
correctly folded. L. amazonensis treated with Vu-Defr led to the elimination of 54.3% and 46.9% of thependent
ersidade
G.S. Souza et al. / Experimental Parasitology 135 (2013) 116–125 117parasites at 24 and 48 h of incubation time, respectively. Vu-Def eliminated 50% and 54.8% of the para-
sites at 24 and 48 h, respectively. Both were used at a concentration of 100 lg/mL. These results sug-
gested the potential for plant defensins to be used as new antiparasitic substances.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs), are differentiated from other
antibiotic peptides, such as gramicidins and polymyxins, which
are synthesized by large enzymatic complex and bear modiﬁed
amino acids including D-amino acids (Sieber and Marahiel, 2005;
Choi et al., 2009), are short polymers of L-amino acids synthesized
by ribosomes upon which all living organisms rely to defend them-
selves from invaders or competitor microorganisms (Broekaert
et al., 1997; Bulet et al., 1999; Gao et al., 2009; Zasloff, 2002). In
complex organisms, these components are part of the innate im-
mune system, which presents broad spectra of inhibitory activity
against Gram-negative and -positive bacteria, fungi, other para-
sites, and even enveloped viruses such as human immunodeﬁ-
ciency virus and herpes simplex virus (Hancock and Diamond,
2000).
Of all the plant AMPs, the family of plant defensins, which be-
longs to a large superfamily of AMPs named defensins, stands out.
These defensins are found in fungi (Mygind et al., 2005), mollusks
(Charlet et al., 1996), insects (Bulet et al., 1999), birds andmammals
(Ganz, 2004; van Dijk et al., 2008; Tomasinsig and Zanetti, 2005). In
plants they are composed of 45–54 amino acid residues including
eight strictly conserved Cys residues, are approximately 6 kDa
and have a basic pI (Carvalho and Gomes, 2011). The three-dimen-
sional structure consists of three anti-parallel b-strands and one a-
helix and is stabilized by four intramolecular disulﬁde bonds
formed between the four pairs of Cys residues (Almeida et al.,
2002; Fant et al., 1998, 1999; Janssen et al., 2003; Lay et al., 2003;
Liu et al., 2006). These peptides also present two structural motifs
called the Cys-stabilized a-helix b-strand motif (Cornet et al.,
1995) and the c-core motif (Yount and Yeaman, 2004). The latter
is shared with many other AMPs. Plant defensins are endowed with
multiple biological activities, such as the ability to halt protein
translation in a cell-free system (Mendez et al., 1990, 1996), inhibit
a-amylase activity (Bloch and Richardson, 1991; Mendez et al.,
1996; Santos et al., 2010; Pelegrini et al., 2008), Ca+2 and Na+ chan-
nels (Kushmerick et al., 1998; Spelbrink et al., 2004) and trypsin
activity (Huang et al., 2008; Wijaya et al., 2000), regenerate dehy-
droascorbate to ascorbic acid in the presence of glutathione (Huang
et al., 2008) andmaintain plant self-incompatibility (Doughty et al.,
1998; Nasrallah et al., 1991). They also play roles in the plant re-
sponse to abitoic stresses (Koike et al., 2002; Mirouze et al.,
2006). The most prominent activity of those cited above are the
activities related to plant defense, with includes antifungal activity
(Almeida et al., 2002; Games et al., 2008; Mello et al., 2011; Osborn
et al., 1995; Portieles et al., 2010; Rogozhin et al., 2011; Solis et al.,
2007; Tavares et al., 2008; Vijayan et al., 2008;), antibacterial activ-
ity (Chen et al., 2005; Osborn et al., 1995; Terras et al., 1992, 1993;
Wong et al., 2006; van der Weerden et al., 2008), and activity
against dicotyledonous obligate root plant parasites (Letousey
et al., 2007). In regard to the antimicrobial activity, it is interesting
that plant defensins are active against human pathogens such as
Candida (Games et al., 2008; Tavares et al., 2008) and have more re-
cently demonstrated activity against the Leishmania donovani pro-
tozoan (Berrocal-Lobo et al., 2009).
More than 350 million individuals in 88 countries are at risk of
infection from parasitic diseases including Leishmaniasis. It is en-
demic in American, Asian and African countries and in southernEuropean countries. There is increasing concern that currently
used drugs will soon become ineffective due to parasite resistance
becoming more prevalent and the fact that there is no effective
vaccination against Leishmaniasis (Cobb and Denny, 2010; Renslo
and McKerrow, 2006). Consequently, there is a need for new drugs
to treat this neglected disease. AMPs have received a great deal of
attention from the scientiﬁc community as possible new therapeu-
tic substances to offset the rise of these pathogens (Giuliani et al.,
2007; Yeung et al., 2011).
We have reported the cloning (Carvalho et al., 2006) and over-
expression of the recombinant Vigna unguiculata defensin (Vu-
Defr) in Escherichia coli (Santos et al., 2010), which was originally
obtained from the seeds of this plant. In this work, we introduced
some modiﬁcations to improve the expression of Vu-Defr and al-
tered the puriﬁcation system to improve the puriﬁcation process.
Additionally, as previously mentioned, despite the broad inhibitory
activity of plant defensins, almost nothing is known about their
activity against protozoa. For this reason, we explored Vu-Defr
activity against the protozoan Leishmania amazonensis. We also
compared the activity of Vu-Defr to the natural V. unguiculata
defensin (Vu-Def) in order to demonstrate the correct expression
and folding of Vu-Defr.
2. Materials and methods
2.1. Biological material
Cowpea (V. unguiculata L. Walp.) seeds were supplied by Uni-
versidade Federal do Ceará, Fortaleza, Brazil.
E. coli strain Rosetta-gami 2 (DE3) pLysS [genotype: D(ara–
leu)7697 DlacX74 DphoA PvuII phoR araD139 ahpC galE galK rpsL
(DE3) F’[lac+ lacIq pro] gor522::Tn10 trxB pLysSRARE23 (CamR, StrR,
TetR)4)] was acquired from Novagen. Luria–Bertani (LB, 0.5% yeast
extract, 1% tryptone, 1% NaCl) and Terriﬁc Broth (TB, 2.4% yeast ex-
tract, 1.2% tryptone, 0.45% glycerol, 1.3% K2HPO4, 0.38% KH2PO4)
were used as expression media, both supplemented with ampicil-
lin (50 lg/mL) and chloramphenicol (34 lg/mL).
L. amazonensis, Josefa strain, at the promastigote stage, was sup-
plied by Laboratório de Biologia Tecidual, Centro de Bioiências e
Biotecnologia, Universidade Estadual do Norte Fluminense Darcy
Ribeiro, Campos dos Goytacazes, Rio de Janeiro, Brazil. The proto-
zoan was cultivated in 5 mL of Warren’s medium (90% Brain heart
broth, Fluka, containing 10% heat-inactivated fetal bovine serum),
enriched with 0.01% folic acid and 0.4% hemin at 28 C with trans-
fer to new medium every three days.
2.2. Puriﬁcation of the natural defensin
The natural defensin from seeds of V. unguiculata (Vu-Def) was
puriﬁed as previously described (Carvalho et al., 2001) with mod-
iﬁcations (Santos et al., 2010) and is described in details as follows.
Fine ﬂour (100 g) was prepared from the seeds of V. unguiculata in a
mill. Proteins and peptides were extracted from this ﬂour with
500 mL extraction buffer (10 mM Na2HPO4, 15 mM NaH2PO4,
100 mM KCl, 1.5% EDTA) for 2 h at 4 C with constant agitation.
The homogenate was centrifuged at 15,000g and the supernatant
was fractionated between 0% and 30% relative ammonium sul-
phate saturation by 18 h at 4 C. After centrifugation at the same
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relative ammonium sulphate saturation by 18 h at 4 C. Again cen-
trifuged at the same conditions and the precipitate was redissolved
in distilled water and heated at 80 C for 15 min. The resulting sus-
pension was centrifuged at 8000g and the supernatant extensively
dialyzed against distilled water for three days. The dialyzed solu-
tion was recovered by freeze drying, and named F/30–70, and then
submitted to further puriﬁcation by chromatographic methods.
Initially a DEAE-Sepharose column (10  1.5 cm), equilibrated with
20 mM Tris–HCl (pH 8.0) at ﬂow rate of 1 mL/min, was used to ob-
tain a basic fraction, called F1, non-retained in the column and
eluted in the equilibrium buffer. Bound proteins (F2) were eluted
with 1 M NaCl in the same buffer. F1 fraction was pooled, concen-
trated by freeze drying and submitted to one cycle of gel ﬁltration
chromatography in Sephadex G-50 (column of 50  1.5 cm) equil-
ibrated and developed in 20 mM Tris–HCl buffer (pH 8.0) at
0.3 mL/min. The column was calibrated with several proteins of
known molecular masses (bovine serum albumin, ovalbumin, soy-
bean trypsin inhibitor and ribonuclease). The peak containing pep-
tides with molecular mass varying from 6 to 10 kDa was collected,
concentrated by freeze drying and resuspended in 0.1% (v/v) triﬂu-
oroacetic acid (TFA) and injected onto an HPLC C2C18 reversed-
phase column (lRPC C2/C18 ST 4.6/100, GE Healthcare) attached
to a C8 guard column (Pelliguard, Sigma). The chromatography
was developed at a ﬂow rate of 0.5 mL/min with 100% solvent A
(0.1% TFA and 2% acetonitrile) for 10 min, 0–100% solvent B (80%
acetonitrile containing 0.1% TFA) over 80 min, 100% solvent B over
85 min, 100–0% solvent B over 90 min, and 100% solvent A for
5 min.
2.3. Expression of recombinant Vu-Def in E. coli
Initially the induction was performed in LB or TB media. Cells
containing the Vu-Defr clone were grown at 37 C in both media
supplemented with antibiotics until the optical density at
600 nm reached an absorbance value between 0.5 and 1.0, at which
point the cells were induced with 1 mM IPTG. After 3 h of induc-
tion at 30 C/27 C, cells were harvested by centrifugation
(15,400g for 10 min at 4 C), resuspended in resuspension buffer
(50 mM sodium phosphate, pH 8.0, 300 mM NaCl) and immedi-
ately lysed by sonication with two bursts of 30 s in the presence
of a inhibitor cocktail (Protease inhibitor cocktail for general use,
Sigma) and 0.1% Triton X-100. This crude lysate was centrifuged
at 15,400g for 5 min at 4 C, and the supernatant protein content
was quantiﬁed by the bicinchoninic acid method (Sigma) with
albumin from chicken egg whites (Sigma) used as the protein
standard.
Improved induction conditions were used to produce Vu-Defr in
large cultures as follows. Singles colonies were used to inoculate a
starter culture of TB medium, which was incubated at 37 C for
16 h at 250 rpm. This culture was diluted 50-fold into fresh TB
medium and incubated in the same conditions until the optical
density at 600 nm reached a value between 0.5 and 1. At a density
between these values, IPTG was added to the culture to a ﬁnal con-
centration of 1 mM. The culture was maintained under induction
at 27 C for 3 h at 250 rpm. After this period, the cells were sedi-
mented, resuspended and lysed as described above.
2.4. Gel electrophoresis
Protein analyses were performed on a 12% SDS–PAGE as de-
scribed by Laemmli (1970) or tricine–SDS–PAGE as described by
Schägger and von Jagow (1987). Prior to electrophoresis, samples
were reduced by boiling them in sample buffer containing
125 mM Tris–HCl pH 6.8, 2% sodium dodecyl sulfate (SDS), 10% sac-
charose, 0.25% bromophenol blue containing 5% b-mercaptoethanolfor 12% SDS–PAGE and 125 mM Tris–HCl pH 8.0, 2.5% SDS, 15% sac-
charose and 0.25% bromophenol blue containing 5% b-mercap-
toethanol for the tricine gel. Gels were stained with Coomassie
Brilliant blue R-250 or silver precipitation and protein markers
from 66,000 to 20,000 Da were used as standards (Sigma) for
SDS–PAGE and from 19,950 to 2510 Da for tricine–SDS–PAGE
(MW-SDS-17S, Sigma).
The best expression condition was evaluated after induction in
the conditions described above. Aliquots of 10 lL of the superna-
tants of the inductions in the different conditions were loaded on
gels as described above. The gels were stained with freshly pre-
pared stain solution. The bands that corresponded to the induced
recombinant defensin were submitted to densitometric analysis
by with the program Gel-Perfect (Bozzo and Retamal, 1991; Ret-
amal et al., 1999). The estimated induction of Vu-Defr was calcu-
lated for each condition by comparing the area of the smallest
band that was considered 100%.
2.5. Obtention of the Vu-Defr
A volume of the supernatant of the crude cell lysate correspond-
ing to 30 mg of protein was applied to a Ni+-NTA agarose column
(Qiagen) previously equilibrated with resuspension buffer without
inhibitor cocktail. The resin was washed with seven volumes of the
same buffer containing 55 mM imidazole and followed by seven
volumes of the same buffer containing 500 mM imidazole. The
non-retained and retained samples were dialyzed against distilled
water and recovered by lyophilization. The retained sample and
that eluted with 500 mM imidazole, which corresponded to Vu-
Defr fused to the Trx and His tags, were treated with the endopro-
teinase enterokinase (EK).
The treatment with the recombinant EK (Sigma) was performed
according to the instruction manual. After cleavage, the sample
was reloaded on the Ni+-NTA agarose column in the same condi-
tions as described above to eliminate the Txr and His tags from
the mature sequence of the peptide. The obtained non-retained
fraction were dialyzed and lyophilized. The quality of cleavage con-
ditions was monitored by electrophoresis.
The non-retained fraction of the second Ni+-NTA agarose col-
umn was diluted in 0.1% (v/v) triﬂuoroacetic acid (TFA, Fluka)
and injected onto an HPLC (Prominence, Shimadzu) C18 re-
versed-phase column (250  4.6 mm, Shimadzu) (attached to a
C8 pre-column (20  4.6 mm, Pelliguard, Sigma–Aldrich). The sol-
vent ﬂow rate was 0.6 mL/min and the solvent progressed from
100% solvent A (0.1% TFA in water) for 5 min, 0–10% solvent B
(100% 2-propanol (Merck) containing 0.1% TFA) for 10 min, 28%
solvent B for 125 min, 65% solvent B for 1 min, returned to 0% sol-
vent B for 1 s and then remained at 0% solvent B for 6 min. The elu-
tion of the fractions was monitored by on-line measurement of the
absorbance at 220 and 280 nm.
2.6. Circular dichroism spectroscopy
Vu-Defr and Vu-Def, both at 15 lg/mL, were dissolved in ultra-
pure water (TEDIA) and transferred to a 5 mm path length quartz
cuvette. Circular dichroism (CD) spectra for both peptides were
separately recorded in a J815 CD spectrometer (Jasco) from the
far-ultraviolet range (185–275 nm) at 20 C. Five scans for each
peptide were performed per spectrum at a speed of 10 nm/min.
The plot was drawn based on an average of ﬁve scans.
2.7. Growth inhibition assay on L. amazonensis promastigotes treated
with Vu-Def and Vu-Defr
An aliquot of the cell culture of L. amazonensis promastigotes
was counted in a Neubauer chamber, and the protozoa cell number
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diluted in dimethyl sulfoxide (DMSO), Warren’s medium and ster-
ilized by ﬁltration (Millex-GV 0.22 lm, Millipore). Twenty micro-
grams of Vu-Def or Vu-Defr, 3 lL of 100% DMSO (1.5% ﬁnal
concentration), 100 lL of Warren’s medium containing the proto-
zoa were added to wells of a culture plate, and the ﬁnal volume
was brought to 200 lL with Warren’s medium. The ﬁnal concen-
tration of Vu-Def or Vu-Defr was 100 lg/mL. The culture was incu-
bated at 28 C for until 48 h. The protozoan cell growth was
determined at 24 and 48 h by cell counting in a Neubauer chamber.
Controls were performed as described by excluding Vu-Def or Vu-
Defr. The assay was done in triplicate, and the results shown are
the average of the cell growth with regard to time for each treat-
ment. Calculations of the standard deviation and Tukey’s test were
done with Prism software (version 5.0).
2.8. Time course of growth inhibition assay of L. amazonensis
promastigotes treated with Vu-Defr
Culture of L. amazonensis promastigotes was prepared as de-
scribed in item 2.7 with cell number adjusted to 1.43  106 para-
sites/mL. Vu-Defr was prepared as described in item 2.7, also at
the concentration of 100 lg/mL. The growth of L. amazonensisFig. 1. Electrophoretic visualization and densiometric analysis in SDS–PAGE of the
best expression conditions of Vu-Defr. Samples from the induced medium in LB and
TB; the arrow indicates the recombinant defensin (Vu-Defr). Below this gel is
indicated the increased percent expression of Vu-Defr induced in TB medium in
comparison to the LB medium. Gel stained with Coomassie.
Fig. 2. Electrophoretic visualization of the different steps of the puriﬁcation of the V
Ni+-NTA agarose column in SDS–PAGE. NI, total non-induced bacterial extract. I, ind
NR, non-retained fraction from the Ni+-NTA agarose column. R, retained fraction f
indicates Vu-Defr after puriﬁcation. (B) Electrophoretic visualization of the cleav
induced (used as control). R, retained fraction in the Ni+-NTA agarose column and
showed contaminants of low molecular mass that were not observed in the SDS–P
enterokinase, the arrow indicates Vu-Defr. (C) Electrophoretic visualization by tric
the Ni+-NTA agarose column after cleavage, this fraction now corresponds to Vu-De








assiepromastigotes were monitored in the times of 0, 8, 16, 24, 32 and
48 h by cell counting as described in item 2.7. A positive control
with amphotericin B (Cristália) at 100 lg/mL, prepared as Vu-Defr,
was included. For the 0 h counting, immediately after the parasite
has been added to the medium containing the Vu-Defr and ampho-
tericin B, the culture was homogeneous mixed and counted.
3. Results
3.1. Expression of Vu-Defr in E. coli
Previously we had expressed the Vu-Defr in E. coli at 37 C for
3 h by induction with 1 mM IPTG. After induction the Vu-Defr
was extracted from the bacteria by sonication pulses and the ex-
tract, after a centrifugation step, was heated to 90 C for 30 min
(Santos et al., 2010). To improve the overexpression of Vu-Defr,
were introduced newmodiﬁcations to the previously used method.
The pre-inoculum was growth at 37 C for 16 h at 250 rpm, chan-
ged the induced medium from LB medium to TB medium, de-
creased the temperature of the induction phase from 37 to 27 C
and after the bacterial extraction we abolished the warm step.
Densitometric analysis in SDS–PAGE demonstrated that the pro-
tein band corresponding to Vu-Defr increased 470% in this new
condition in comparison to that one used previously (Fig. 1).
The crude bacterial lysate obtained contain the Vu-Defr fused
with thioredoxin (Trx) and histidine (His) tags and analysis in
SDS–PAGE demonstrated that the recombinant Vu-Defr presented
a molecular mass of approximately 27 kDa (Fig. 2A, white arrow).
The His tag allow the interaction of the recombinant protein with
metals and for this reason we submitted the crude bacterial extract
to a metal afﬁnity chromatography in a Ni+-NTA agarose. The col-
umn was developed with three buffers, the equilibrium buffer in
which the crude bacterial extract was load into the column, the
equilibrium buffer containing 55 mM imidazole in which the non-
retained fraction was eluted from the column and the equilibrium
buffer containing 500 mM imidazole in which the retained fraction
was eluted from the column. This last one corresponds to the frac-
tion that has afﬁnity to the Ni coupled to the column. Analysis in
SDS–PAGE demonstrated that the retained fraction presented only
one protein band of molecular mass of approximately 27 kDa
(Fig. 2A, arrow in R). This retained fraction, which is correspond to
theVu-Defr fusedwith the thioredoxin (Trx) andhistidine (His) tags,
was treated with enterokinase (EK) that recognize a speciﬁc cleav-
age site located between the histidine (His) tag and Vu-Defr. Afterr. (A) The ﬁrst step puriﬁcation of Vu-Defr from the soluble bacterial extract after the
total bacterial extract. The white arrow indicates Vu-Defr expressed after induction.
he Ni+-NTA agarose column and that eluted with 500 mM of imidazole. The arrow
the Trx and His tags from Vu-Defr by tricine–SDS–PAGE. I, total bacterial extract
eluted with 500 mM of imidazole, used as cleavage control. The tricine–SDS-PAGE
li, represents the retained fraction in the Ni+-NTA agarose column (R) treated with
S–PAGE of puriﬁcation of Vu-Defr after cleavage. Vu-Defr, non-retained fraction in
ld arrow). R, retained fraction in the Ni+-NTA agarose, this fraction now corresponds
.
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recuperated after new chromatographic round in the Ni+-NTA-aga-
rose as described in item 2.5. However this time the interested frac-
tion was the non-retained which corresponded to the Vu-Defr thatFig. 3. Electrophoretic visualization by tricine–SDS–PAGE of puriﬁcation of the
natural defensin (Vu-Def, bold arrow) from Vigna unguiculata seeds. M, molecular
mass marker in kDa. Gel stained with Coomassie.
Fig. 4. Final step in puriﬁcation of Vu-Defr. (A) Chromatogram of the non-retained fractio
column in HPLC. Thirteen peaks were obtained, one not retained (P1) and 12 (P2–P13) ret
tricine–SDS–PAGE of the 13 different peaks of the C18 column. Vu-Defr was obtained inlost afﬁnity to the coupled Ni+ of the column because it is no more
fused to the His tag. The retained fraction corresponds now to the
tags. Analysis in tricine–SDS–PAGE of these fractions demonstrated
that after EK cleavage the band of approximately 27 kDa disappear
and new bands appear, among them is one of approximately of
7 kDawhich corresponds to the Vu-Defr (Fig. 2B, Cli). Lowmolecular
weight contaminants are observed in the R sample before the EK
treatment (Fig. 2B, R) that were not seen in the SDS–PAGE
(Fig. 2A, R). The fraction (Cli) containing Vu-Defr separated from
the tags (Trx and His) was subjected to same column and yielded
Vu-Defr (Fig. 2C) and the tags (Trx and His), labeled R in Fig. 2C.
The puriﬁcation of Vu-Defrwas completed by running it on a C18 re-
versed-phase column (Fig. 4). The natural Vu-Def, puriﬁed from ex-
tract of V. unguiculata seeds, is shown in Fig. 3 and it presented the
same molecular mass in tricine–SDS–PAGE that Vu-Defr.3.2. Biological activity of Vu-Defr
To evaluate the functional expression of Vu-Defr we compared
circular dichroism (CD) spectra and activity against L. amazonesis
promastigotes with Vu-Def (the natural defensin puriﬁed from
the V. unguiculata seed). The CD spectra of both peptides presented
good superimposition, with a maximum at 196 nm and a mini-n from the Ni+-NTA agarose column after cleavage loaded onto a C18 reversed-phase
ained and eluted with a linear propanol gradient. (B) Electrophoretic visualization in
the last peak. M, molecular mass marker in kDa. Gel stained with Coomassie.
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secondary structures and that the Vu-Defr was correctly folded
during the recombinant production (Fig. 5).
The inhibition of L. amazonensis promastigotes growth was also
evaluated with both defensins with the main intent to verify if the
Vu-Defr after the recombinant production was as biologically ac-
tive as its natural counterpart. Vu-Defr eliminated 54.3% and
46.9% of the protozoa growth at 24 and 48 h, respectively, and
Vu-Def eliminated 50% and 54.8% of the protozoa growth at 24
and 48 h, respectively, both defensins at the concentration of
100 lg/mL (Fig. 6). Statistical analysis of Vu-Defr and Vu-Def elim-
ination percentage demonstrated that they are not signiﬁcantly
different conﬁrming that Vu-Defr retained full biological activity
after the recombinant production.
The effect of Vu-Defr on L. amazonensis promastigotes cell
growth has been accompanied at 0, 8, 16, 24, 32 and 48 h at
100 lg/mL. In the graphic of Fig. 7 is observed that from 0 to 8 h
the number of the protozoan cells per mL drop from 1.375  106
to 0.975  106, it means that 30.1% protozoan cells were elimi-
nated by the Vu-Defr. In regard to the control of 8 h, there was
an elimination of 33.3%. Moving to the next time the number of
L. amanzonensis cells per mL treated with the Vu-Defr remains al-
most constant, being 0.925  106, however as the control growth
21.4% in regard to the control of 8 h, and so the elimination of
the protozoan by Vu-Defr rose to 47.9% to this time point. This rea-
soning can be applied to the other times. These data from 8 and
16 h means that the L. amazonensis cells treated with Vu-Defr were
not growing during 16 h. At 24 h after the initial contact with the
Vu-Defr the number of the L. amazonensis cells per mL (1.2  106)
start to rise in comparison to the cell number at 0 h. This increasingFig. 5. Superimposition of circular dichroism spectra of the natural Vu-Def (black
line) and Vu-Defr (gray line). Mdeg – millidegrees.
Fig. 6. Growth inhibition assay of Leishmania amozonensis in the absence (control) and pr
Growth was observed after 24 and 48 h. The percent of protozoan elimination in regard to
the Tukey test (P < 0.01) among the experiments and their respective controls. (⁄2) indicat
and between Vu-Defr 48 h and Vu-Def 48 h. Experiments were done in triplicate and thin cell number per mL of the treated samples is observed from this
time on. In regard to the controls of each time the growth inhibi-
tion was 45.6%, 40.0%, 41.6% for 24, 32 and 48 h, respectively.
The protozoan cells treated with the reference drug, amphoterecin
B, at the same concentration of the Vu-Defr were completed elim-
inated since the time of 8 h (Fig. 7).4. Discussion
The pervasive problem in recombinant protein expression in
bacterial systems is insolubility, especially if the protein possesses
Cys bonds, as the majority of AMPs do. In the prokaryotic system,
the correct formation of the Cys bonds is an intrinsic problem that
leads to incorrect folding and aggregation of the recombinant pro-
tein in precipitates called inclusion bodies. Misfolding also abro-
gates biological activity. Another problem is codon bias, which
leads to low or absent recombinant protein synthesis, premature
termination and misincorporation of amino acids into the recombi-
nant protein (Gräslund et al., 2008).
To overcome the problem of disulﬁde bond formation, fusion
proteins that are directed to the bacterial periplasmic space where
they can be correctly processed with assistance from a disulﬁde
isomerase have been used (Nakamoto and Bardwell, 2004). An-
other approach is based on the mutation of genes that alter the re-
dox state of the bacterial cytoplasm and thus permit the correct
formation of disulﬁde bonds (Derman et al., 1993). The problem
of codon bias has been solved by the incorporation of a plasmid
that supplies all rare codons used by eukaryotic system into the
bacterial host (Baca and Hol, 2000).
To choose the best system to produce Vu-Defr and account for
these problems, we initially scrutinized some previously published
reports on the production of AMPs in both prokaryotic and eukary-
otic systems (Alves et al., 1994; Chen et al., 2005; Elmorjani et al.,
2004; Kristensen et al., 1999; Lullien-Pellerin et al., 1999; Song
et al., 2005), and we also consulted the technical manuals of some
cloning system manufacturers. From these analyses, we chose the
pET32 EK/LIC vector from Novagen (see description in the materi-
als and methods section) and the Rosetta-gami 2 DE3 pLysS strain
as the bacterial host. The combination of these two systems allevi-
ated the aforementioned problems and generated soluble and bio-
logically active Vu-Defr (Fig. 2) as compared with its natural
counterpart, Vu-Def, obtained directly from V. unguiculata seeds
(Fig. 3 and 4). Additionally, the CD spectra of Vu-Defr and Vu-Defesence of 100 lg/mL of both recombinant (Vu-Defr) and natural (Vu-Def) defensins.
their respective controls is shown above the gray bars. (⁄1) indicates signiﬁcance by
es no signiﬁcance by the Tukey test (P < 0.01) between Vu-Defr 24 h and Vu-Def 24 h
e results presented are average with standard deviation.
Fig. 7. Time course of growth inhibition assay of Leishmania amozonensis promastigotes in the absence (control) and presence of 100 lg/mL of recombinant defensin (Vu-
Defr) and amphotericin B (AmphB). Growth was observed at 0, 8, 16, 24, 32 and 48 h. The percent of protozoan elimination in regard to their respective controls is shown
above the gray bars. To the time of 0 h, immediately after the parasite has been added to the medium containing the Vu-Defr and amphotericin B, the culture was
homogeneous mixed and counted. The protozoan cells treated with the reference drug, amphoterecin B, were completed eliminated since the time of 8 h.
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peptides have the same secondary structure and that they are prin-
cipally composed of b-strand secondary structure (Fig. 5), which is
characteristic of plant defensins (Fant et al., 1998; Liu et al., 2006).
In comparison to Vu-Def, Vu-Defr has an additional methionine
at its N-terminus. This addition is an artifact of cloning the peptide
into the pET-32 EK/LIC vector. However, this addition did not inter-
fere with the global structure of Vu-Defr, as demonstrated by the
CD analysis (Fig. 5), or with its antimicrobial activity, as demon-
strated by the antimicrobial assay (Fig. 6). Other expression sys-
tems add extra amino acids to the expressed recombinant
peptides, and these extra amino acids were not reported to inter-
fere with the biological activity of the recombinant peptide (Chen
et al., 2004; de Zélicourt et al., 2007).
The plant defensin Vu-Defr and its natural counterpart pre-
sented activity against L. amazonensis promastigotes. At 100 lg/
mL, Vu-Defr and Vu-Def inhibited approximately 50% of the growth
of the protozoan at 48 h of incubation time (Fig. 6). The concentra-
tion of 100 lg/mL of Vu-Def and Vu-Defr was chosen taking in con-
sideration the difﬁculty in obtain more quantity of Vu-Def at the
end of the puriﬁcation processes. Berrocal-Lobo et al. (2009) tested
the activity of four plant AMPs against L. donovani promastigotes.
Among them, only the thionin and the PTH1 defensin were able
to inhibit this protozoan. The PTH1 defensin, similar to Vu-Defr
and Vu-Def, also inhibited approximately 50% of the protozoan pro-
liferation with incubation time of 48 h, though its concentration
was 5.4 lM (approximately 27 lg/mL). Other results also indicate
that, depending on the identity of the AMP and protozoan, there
is variability in the concentration necessary to inhibit growth (Bera
et al., 2003; Kulkarni et al., 2006). The antimicrobial activity of
plant defensins is mainly directed against fungi (Almeida et al.,
2002; de Beer and Vivier, 2011; Osborn et al., 1995; Rogozhin
et al., 2011; Segura et al., 1998; Terras et al., 1992; Wu et al.,
2011), which most likely pose a stronger pressure upon plants dur-
ing evolution, thereby molding or redirecting the activity of these
plant peptides against them. However, even among fungi, the
activity of plant defensins is dependent on the identity of the
tested fungi and the plant defensin (Almeida et al., 2002; de Beer
and Vivier, 2011; Osborn et al., 1995; Rogozhin et al., 2011; Segura
et al., 1998; Terras et al., 1992; Wu et al., 2011). Reported concen-
trations range from 0.4 lg/mL for Rs-AFP2 and Pyricularia oryzae
(Terras et al., 1992) to higher than 100 lg/mL for Psd1 and Fusar-ium oxysporum (Almeida et al., 2002). Such variation in the concen-
tration used to cause inhibition can be explained by the small
variability in the spatial structure of plant defensins dictated by
the different primary structures presented by the molecules (Carv-
alho and Gomes, 2011).
Leishmania have developed methods to evade the activity of
AMPs. Protozoa from the kinetoplastid order produces an anionic
glycocalix, known in Leishmania as lipophosphoglican (LPG)
(Descoteaux and Turco, 1999), which is supposed to act as an anio-
nic barrier to AMPs. Proteases (Kulkarni et al., 2006; Mottram et al.,
2004) known to have broad proteolytic activity against several pro-
teins are also produced. In regard to LPG, studies comparing the
activity of indolicitin and the seminalplasmin-derived peptides
SPFK and 27RP on wild type L. donovani and a mutant strain lacking
LPG demonstrated that the mutant strain is less susceptible to
these peptides (Bera et al., 2003). In regard to proteases, the AMPs
a-defensin cryptidin-4, human b defensing-3, cyclic defensin the-
ta-II, cathelicidin protegrin-1 and pexiganan (a magainin analog
originally obtained from the skin of the African clawed frog) pre-
sented a stronger activity on a mutant of Leishmania major that
lacks the major surface metalloprotease leishmanolysin (Kulkarni
et al., 2006). Our results demonstrate that these protection mech-
anisms do not affect the activity of the defensin from V. unguiculata
seeds.
Defensins have therapeutic potential because they are less toxic
than other AMPs. Plant AMPs such as thionins are very toxic and
present activity against many cell types (Florack and Stiekema,
1994). According to the Berrocal-Lobo et al. (2009) the appropriate
inhibitory concentration is very similar for L. donovani and other
organisms. This general toxicity and very similar inhibitory con-
centrations for pathogens and mammalian cells suggests that thio-
nins should not be used as possible therapeutic substances. In
contrast, plant defensins presented very low toxicity to mamma-
lian cells, which is only observed at higher concentrations of plant
defensins (Tavares et al., 2008; Terras et al., 1992). Additionally, Rs-
AFP2 has been injected intravenously into mice experimentally in-
fected with Candida albicans, and diminution of the burden and low
toxicity to the mice that survived was observed (Tavares et al.,
2008).
The Fig. 7 demonstrated that the used concentration of 100 lg/
mL of Vu-Defr is enough to eliminate 30.1% of the protozoan cells
after 8 h of contact. The survived cells to the exposition of Vu-Defr
G.S. Souza et al. / Experimental Parasitology 135 (2013) 116–125 123in the culture, which correspond to 69.9% of the original cell num-
ber at 0 h, start to rise again at 24 h. Plant defensins, in regard to
the fungicidal and fungistatic effect, present the fungicidal effect
as already demonstrated to plant defensins isolated from Heuchera
sanguinea (coral bells, Hs-AMP1), Raphanus sativus (radish, Rs-
AFP2) and Dahlia merckii (dahlia, Dm-AMP1) (Thevissen et al.,
2007) and Nicotiana alata (NaD1) (van der Weerden et al., 2010).
In the aforementioned examples the cell viability assay clearly
indicated the punctual concentration of the plant defensins used
are enough to kill some cells of the total population while others
still stay viable. In this sense is particularly interesting the result
of the method of colony forming units of the viability assay de-
scribed in Thevissen et al. (2007), which demonstrated that the ex-
posed cells to plant defensins can restart growth. The outcome of
the interaction of the plant defensins with microbial cells have
been described as multifaced phenomenon. The interaction can re-
sult in ion ﬂux across and membrane depolarization (Thevissen
et al., 1996), membrane permeabilization (Thevissen et al., 1999;
van der Weerden et al., 2010) and induction of reactive oxygen
species and oxide nitric (Aerts et al., 2007; Mello et al., 2011). It
is also known that plant defensins, exempliﬁed by PsD1 (a defensin
isolated from Pisum sativum seeds) (Lobo et al., 2007) and NaD1
(van der Weerden et al., 2010) enter in the cytoplasm of fungal
cells. Inside the cell the peptide has the possibility to interact with
intracellular targets. In the speciﬁc case of PvD1, this interacts with
cyclin F from Neurospora grassa and interferes with fugal growth
and with interkinetic nuclear migration in rat retina, a model for
cell cycle (Lobo et al., 2007). Although these effects have been de-
scribed to fungi, they have been also demonstrated to other AMPs
in regard to protozoan inhibition. Mangoni et al. (2005) have dem-
onstrated the effect of temporins (AMP isolated from the skin
secretion of the amphibian Rana temporaria) causes loss of viability
of some cell population, membrane depolarization and membrane
permeabilization in L. donovani. Kulkarni et al. (2009) have demon-
strated the intracellular localization of pexiganan (an analog of the
AMP magainin2 from skin secretion of Xenopus laevis) in L. major.
As the toxic effect is concentration dependent, the fate of the cell
is determined by its ability to surmount the pleotropic effects of
AMPs on its physiology.
In conclusion, we demonstrated the correctly folded and biolog-
ically active E. coli overexpression of a plant defensin originally ob-
tained from seeds of V. unguiculata, Vu-Defr. Additionally, we
demonstrated the activity of the recombinant defensin against L.
amazonensis promastigotes and that the effect of Vu-Defr on L.
amazonensis is concentration dependent and that at 100 lg/mL ef-
fect is lethal to the some L. amazonensis cell population. Future
studies will be done to unravel the mechanism of action of Vu-Defr
on L. amanzonensis.Acknowledgments
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